MK0663
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for MK0663, covering 2010-01-29 to 2024-08-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED) [Phase 3]